Intragastric Balloons Market Outlook 2025-2034: Market Share, and Growth Analysis

The Intragastric Balloons Market is valued at USD 19.3 billion in 2025 and is projected to grow at a CAGR of 12.5% to reach USD 55.9 billion by 2034.

The Intragastric Balloons Market centers on a non-surgical, temporary weight loss intervention designed for patients with obesity who have struggled with traditional methods such as diet, exercise, or medications. These balloons are inserted endoscopically or swallowed in capsule form, then inflated with saline or gas to occupy space in the stomach and induce satiety, helping patients reduce food intake. Typically approved for use over six months, they serve as a bridge therapy for individuals not yet eligible for or unwilling to undergo bariatric surgery. With global obesity rates soaring and growing demand for less invasive, reversible weight loss options, intragastric balloons are gaining popularity among both patients and healthcare providers. The market includes devices from major players such as Allurion Technologies, Apollo Endosurgery, and Spatz Medical, and is driven by increasing acceptance of interventional weight management programs integrated with nutrition and behavioral counseling.

The intragastric balloons market saw renewed momentum, especially in regions like the U.S., Europe, and the Middle East. Allurion's swallowable, procedure-free balloon gained widespread attention for its convenience and scalability, reducing the need for endoscopy or sedation. Providers increasingly bundled balloon placement with structured digital weight management programs, offering coaching apps, dietary tracking, and real-time feedback to improve long-term outcomes. Clinics reported higher demand among patients seeking pre-surgical weight loss to qualify for orthopedic or fertility procedures. Meanwhile, long-term outcome studies began to shed light on the sustainability of weight loss post-balloon removal, prompting innovation in follow-up care protocols. Insurers in select markets began piloting reimbursement programs for obesity interventions, creating new access pathways for patients with comorbidities like type 2 diabetes or hypertension. The increased awareness of metabolic health after the COVID-19 pandemic further boosted demand for safe and reversible weight loss solutions.

The intragastric balloons market is expected to evolve through smarter devices, expanded indications, and wider accessibility. Balloon designs will continue to improve, with self-adjusting inflation systems and bioresorbable materials under development to enhance safety and eliminate the need for removal procedures. Integrated digital health platforms will play a greater role in patient adherence and behavior modification, leveraging AI to personalize nutrition and lifestyle guidance. Clinical trials will explore the role of intragastric balloons in early intervention for metabolic syndrome and non-alcoholic fatty liver disease (NAFLD). As obesity treatment becomes a multidisciplinary focus, gastroenterologists, endocrinologists, and behavioral health professionals will collaborate more closely on patient care. Reimbursement policies are also expected to expand, particularly in markets prioritizing preventive health. With the growing emphasis on minimally invasive and lifestyle-oriented solutions, intragastric balloons will solidify their place as a valuable component in the global obesity management toolkit.

Key Insights: Intragastric Balloons Market

• The analyst highlights the rise of swallowable, endoscopy-free intragastric balloons, such as Allurion’s device, which reduce procedural burden and open access to a broader patient base seeking non-invasive weight loss interventions.
• Integration of digital coaching and health apps alongside balloon therapy is trending, allowing for structured, remote weight management programs that improve adherence and extend post-removal success, says the analyst.
• According to the analyst, longer-duration and adjustable balloons are gaining attention, offering customizable volume adjustments and extended treatment cycles to improve weight loss outcomes over time.
• The analyst notes increased use of intragastric balloons as pre-surgical interventions for patients needing to reduce BMI prior to orthopedic, fertility, or other elective procedures.
• New clinical trials are exploring the role of intragastric balloons in treating metabolic conditions beyond obesity, such as insulin resistance and NAFLD, reflecting broader therapeutic potential, the analyst observes.

• The analyst identifies rising global obesity rates and the growing demand for non-surgical, temporary weight loss solutions as primary drivers for increased intragastric balloon adoption.
• Technological advancements - such as capsule-based deployment, gas-filled balloons, and self-removable devices - are improving patient experience and expanding clinical acceptance, says the analyst.
• The analyst notes that integration with structured nutrition and behavioral programs enhances long-term outcomes and positions balloons as a more holistic, lifestyle-oriented obesity management tool.
• Increased payer interest in obesity treatment reimbursement - especially for high-risk patients with comorbidities - is expanding access and creating new market opportunities, according to the analyst.

• The analyst highlights concerns about weight regain post-balloon removal, which emphasizes the need for long-term lifestyle change and follow-up care to sustain weight loss results.
• According to the analyst, high out-of-pocket costs and limited insurance coverage in many regions still restrict balloon adoption to wealthier or self-paying patients, limiting broader market penetration.

Intragastric Balloons Market Segmentation

By Type

• Single
• Dual
• Triple Intragastric Balloons

By Filling Material

• Saline Filled
• Gas Filled

By Distribution Channel

• Online Pharmacies
• Retail Pharmacies
• Hospital Pharmacies

By Application Areas

• Obesity
• Diabetes
• Diet Control
• Weight-loss
• Pre-operative Weight Reduction
• Other Applications

By End-User

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Other End-Users

Key Companies Analysed

• Medtronic plc
• Mayo Clinic
• Boston Scientific Corporation
• Cleveland Clinic
• Mediclinic Group
• Spire Healthcare Group plc
• Micro-Tech (Nanjing) Co.
• Ltd
• American Hospital Dubai LLC
• Silimed GmbH
• Apollo Endosurgery Inc.
• Allurion Technologies Inc.
• MedicalExpo
• ReShape Lifesciences Inc.
• Districlass Medical SA
• Healthware Private Limited
• Spatz Medical
• Helioscopie SA
• Bariatric Solutions International GmbH
• HexaHealth Care Pvt. Ltd.
• USGI Medical Inc.
• Inamed Health
• Medsil
• Obalon Therapeutics Inc.
• Endalis
• Lexel SRL

Intragastric Balloons Market Analytics

The report employs rigorous tools, including Porter’s Five Forces, value chain mapping, and scenario-based modeling, to assess supply-demand dynamics. Cross-sector influences from parent, derived, and substitute markets are evaluated to identify risks and opportunities. Trade and pricing analytics provide an up-to-date view of international flows, including leading exporters, importers, and regional price trends.

Macroeconomic indicators, policy frameworks such as carbon pricing and energy security strategies, and evolving consumer behavior are considered in forecasting scenarios. Recent deal flows, partnerships, and technology innovations are incorporated to assess their impact on future market performance.

Intragastric Balloons Market Competitive Intelligence

The competitive landscape is mapped through proprietary frameworks, profiling leading companies with details on business models, product portfolios, financial performance, and strategic initiatives. Key developments such as mergers & acquisitions, technology collaborations, investment inflows, and regional expansions are analyzed for their competitive impact. The report also identifies emerging players and innovative startups contributing to market disruption.

Regional insights highlight the most promising investment destinations, regulatory landscapes, and evolving partnerships across energy and industrial corridors.

Countries Covered

• North America - Intragastric Balloons market data and outlook to 2034
  • United States
  • Canada
  • Mexico
  
  
• Europe - Intragastric Balloons market data and outlook to 2034
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • BeNeLux
  • Russia
  • Sweden
  
  
• Asia-Pacific - Intragastric Balloons market data and outlook to 2034
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Malaysia
  • Vietnam
  
  
• Middle East and Africa - Intragastric Balloons market data and outlook to 2034
  • Saudi Arabia
  • South Africa
  • Iran
  • UAE
  • Egypt
  
  
• South and Central America - Intragastric Balloons market data and outlook to 2034
  • Brazil
  • Argentina
  • Chile
  • Peru

Research Methodology

This study combines primary inputs from industry experts across the Intragastric Balloons value chain with secondary data from associations, government publications, trade databases, and company disclosures. Proprietary modeling techniques, including data triangulation, statistical correlation, and scenario planning, are applied to deliver reliable market sizing and forecasting.

Key Questions Addressed

• What is the current and forecast market size of the Intragastric Balloons industry at global, regional, and country levels?
• Which types, applications, and technologies present the highest growth potential?
• How are supply chains adapting to geopolitical and economic shocks?
• What role do policy frameworks, trade flows, and sustainability targets play in shaping demand?
• Who are the leading players, and how are their strategies evolving in the face of global uncertainty?
• Which regional “hotspots” and customer segments will outpace the market, and what go-to-market and partnership models best support entry and expansion?
• Where are the most investable opportunities - across technology roadmaps, sustainability-linked innovation, and M&A - and what is the best segment to invest over the next 3-5 years?

Your Key Takeaways from the Intragastric Balloons Market Report

• Global Intragastric Balloons market size and growth projections (CAGR), 2024-2034
• Impact of Russia-Ukraine, Israel-Palestine, and Hamas conflicts on Intragastric Balloons trade, costs, and supply chains
• Intragastric Balloons market size, share, and outlook across 5 regions and 27 countries, 2023-2034
• Intragastric Balloons market size, CAGR, and market share of key products, applications, and end-user verticals, 2023-2034
• Short- and long-term Intragastric Balloons market trends, drivers, restraints, and opportunities
• Porter’s Five Forces analysis, technological developments, and Intragastric Balloons supply chain analysis
• Intragastric Balloons trade analysis, Intragastric Balloons market price analysis, and Intragastric Balloons supply/demand dynamics
• Profiles of 5 leading companies - overview, key strategies, financials, and products
• Latest Intragastric Balloons market news and developments

Additional Support

With the purchase of this report, you will receive:

• An updated PDF report and an MS Excel data workbook containing all market tables and figures for easy analysis.
• 7-day post-sale analyst support for clarifications and in-scope supplementary data, ensuring the deliverable aligns precisely with your requirements.
• Complimentary report update to incorporate the latest available data and the impact of recent market developments.

This product will be delivered within 1-3 business days.